U.S. Home Infusion Therapy Market Size By Product (Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors), By Application (Anti-infective, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals),

U.S. Home Infusion Therapy Market Size By Product (Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors), By Application (Anti-infective, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals), Industry Analysis Report, Zonal Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023 - 2032

The U.S. home infusion therapy market is expected to grow substantially through 2032 owing to the growing preference of consumers towards at-home healthcare systems.

Advancements in technology and the increasing geriatric population across the world have further fueled the market growth. Several renowned companies in the industry are vying for overseas expansion and better opportunities to grow their business in developing states across the US.

In the region, preferences for homecare settings are changing because of increased chronic disease frequency and healthcare costs. One of the frequent inflammatory and autoimmune diseases identified in home healthcare situations is rheumatoid arthritis.

In addition to this, the home infusion therapy demand as well as I.V. infusion therapy is rising as a result of the growing number of sick people, thus positively affecting the market demand.

Furthermore, strategic initiatives like mergers, acquisitions, and product launches by leading industry players would as well expand the market scope for home infusion therapy in the United States. For instance, in September 2022, B. Braun Medical Inc., a global leader in pain management and infusion therapy, revealed the takeover of Starboard Medical, Inc.'s unique Clik-FIX catheter securement device portfolio.

With peripheral intravenous (IV) therapy, B. Braun's purchase expands on the firm’s portfolio of product and program innovation to improve patient experiences and outcomes.

The U.S. home infusion therapy market has been divided in terms of product, application, and zone.

Based on the product, the IV cannulas segment is set to witness ample growth in the market through the forthcoming years. The fundamental purpose of IV cannulas is to deliver antibiotics, fluids, and blood products intravenously with an intent to enhance the condition for which a patient is being treated.

In terms of application, the U.S. home infusion therapy market has been categorized into hydration therapy, anti-infective, enteral nutrition, specialty pharmaceuticals, chemotherapy, and parenteral nutrition.

The hydration therapy segment is slated to proliferate significantly over 2023-2032. Meanwhile, the chemotherapy segment is projected to register considerable growth by the end of 2032. Furthermore, parenteral nutrition is also set to showcase a strong market share over the forecast years. The others segment is expected to expand exponentially through the review timeline.

With respect to zone, the U.S. home infusion therapy industry is diversified into east north central, west south central, east south central, west north central, and mountain states. The east-north central segment is poised to foresee steady growth through the forthcoming years. On the other hand, the mountain states segment is speculated to advance substantially by the end of 2032.